189 related articles for article (PubMed ID: 26916160)
1. Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease.
Lohani N; Rajeswari MR
Curr Protein Pept Sci; 2016; 17(8):762-775. PubMed ID: 26916160
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group box 1 emerges as a therapeutic target for asthma.
Yang Q; Li M; Hou Y; He H; Sun S
Immun Inflamm Dis; 2023 Dec; 11(12):e1124. PubMed ID: 38156383
[TBL] [Abstract][Full Text] [Related]
3. High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts.
Abe A; Kuwata T; Yamauchi C; Higuchi Y; Ochiai A
Pathol Int; 2014 Jun; 64(6):267-75. PubMed ID: 24965109
[TBL] [Abstract][Full Text] [Related]
4. High-mobility group box-B1 (HMGB1) mediates the hypoxia-induced mesenchymal transition of osteoblast cells via activating ERK/JNK signaling.
Qiu Y; Chen Y; Zeng T; Guo W; Zhou W; Yang X
Cell Biol Int; 2016 Nov; 40(11):1152-1161. PubMed ID: 27106169
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 mediates HAdV-7 infection-induced pulmonary inflammation in mice.
Tang Z; Zang N; Fu Y; Ye Z; Chen S; Mo S; Ren L; Liu E
Biochem Biophys Res Commun; 2018 Jun; 501(1):1-8. PubMed ID: 29571731
[TBL] [Abstract][Full Text] [Related]
6. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.
Musumeci D; Roviello GN; Montesarchio D
Pharmacol Ther; 2014 Mar; 141(3):347-57. PubMed ID: 24220159
[TBL] [Abstract][Full Text] [Related]
7. Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses.
Mandke P; Vasquez KM
DNA Repair (Amst); 2019 Nov; 83():102701. PubMed ID: 31563843
[TBL] [Abstract][Full Text] [Related]
8. Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats.
Liu X; Xu Q; Mei L; Lei H; Wen Q; Miao J; Huang H; Chen D; Du S; Zhang S; Zhou J; Deng R; Li Y; Li C; Li H
Int Immunopharmacol; 2018 Aug; 61():169-177. PubMed ID: 29883962
[TBL] [Abstract][Full Text] [Related]
9. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of compound 4,4'-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-κB pathway.
Feng L; Zhu M; Zhang M; Jia X; Cheng X; Ding S; Zhu Q
Int Immunopharmacol; 2013 Feb; 15(2):206-16. PubMed ID: 23219582
[TBL] [Abstract][Full Text] [Related]
11. High-Mobility Group Box 1 Mediates Fibroblast Activity via RAGE-MAPK and NF-κB Signaling in Keloid Scar Formation.
Kim J; Park JC; Lee MH; Yang CE; Lee JH; Lee WJ
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283384
[TBL] [Abstract][Full Text] [Related]
12. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.
Zhang J; Shao S; Han D; Xu Y; Jiao D; Wu J; Yang F; Ge Y; Shi S; Li Y; Wen W; Qin W
Int J Oncol; 2018 Aug; 53(2):659-671. PubMed ID: 29845254
[TBL] [Abstract][Full Text] [Related]
13. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.
Scaffidi P; Misteli T; Bianchi ME
Nature; 2002 Jul; 418(6894):191-5. PubMed ID: 12110890
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia.
Das N; Dewan V; Grace PM; Gunn RJ; Tamura R; Tzarum N; Watkins LR; Wilson IA; Yin H
Cell Rep; 2016 Oct; 17(4):1128-1140. PubMed ID: 27760316
[TBL] [Abstract][Full Text] [Related]
15. Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway.
Cai W; Duan XM; Liu Y; Yu J; Tang YL; Liu ZL; Jiang S; Zhang CP; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():4391920. PubMed ID: 28116308
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.
Urbonaviciute V; Voll RE
J Intern Med; 2011 Oct; 270(4):309-18. PubMed ID: 21793951
[TBL] [Abstract][Full Text] [Related]
17. [HMGB1--its role in tumor progression and anticancer therapy].
Smolarczyk R; Cichoń T; Jarosz M; Szala S
Postepy Hig Med Dosw (Online); 2012 Nov; 66():913-20. PubMed ID: 23175347
[TBL] [Abstract][Full Text] [Related]
18. The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes.
Wang Y; Zhong J; Zhang X; Liu Z; Yang Y; Gong Q; Ren B
J Diabetes Res; 2016; 2016():2543268. PubMed ID: 28101517
[No Abstract] [Full Text] [Related]
19. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A.
Nehil M; Paquette J; Tokuyasu T; McCormick F
Oncogene; 2014 Oct; 33(44):5151-62. PubMed ID: 24213571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
